Cargando…
Severe Symptomatic Hyponatremia Secondary to Escitalopram-Induced SIADH: A Case Report with Literature Review
Hyponatremia is a well-known medication related side effect of selective serotonin reuptake inhibitors; despite its association with escitalopram, the newest SSRI is very rare. We did a review of literature and came across only 14 reported case of this rare association of SIADH with escitalopram. We...
Autores principales: | Raj, Rishi, Jacob, Aasems, Venkatanarayan, Ajay, Doraiswamy, Mohankumar, Ashok, Manjula |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6145057/ https://www.ncbi.nlm.nih.gov/pubmed/30254775 http://dx.doi.org/10.1155/2018/3697120 |
Ejemplares similares
-
Severe hyponatremia associated with escitalopram
por: Rawal, Gautam, et al.
Publicado: (2017) -
A case report of severe hyponatremia secondary to Paxlovid‐induced SIADH
por: Mohamed, Sarah, et al.
Publicado: (2023) -
Acute symptomatic hyponatremia in setting of SIADH as an isolated presentation of COVID-19
por: Habib, Mhd Baraa, et al.
Publicado: (2020) -
Severe hyponatremia due to trimethoprim-sulfamethoxazole-induced SIADH
por: Marak, Creticus, et al.
Publicado: (2022) -
Actual Therapeutic Indication of an Old Drug: Urea for Treatment of Severely Symptomatic and Mild Chronic Hyponatremia Related to SIADH
por: Decaux, Guy, et al.
Publicado: (2014)